Page 52 - JCBP-2-3
P. 52

Journal of Clinical and
            Basic Psychosomatics                                   Proteomic analysis of mind-body psychotherapy in psoriasis




                         A                                     B


























                  Figure 1. Proteomics experiment and analysis workflow. (A) Proteomics experiment workflow. (B) Proteomics data analysis workflow
                            Abbreviations: PPI: Protein and protein interaction; KEGG: Kyoto encylopedia of Genes and Genome.

            2.4. Protein digestion                             mobile  phase B rose from 25% to 35%; 105 – 110 min,
                                                               mobile phase B rose from 35% to 80%; 110 – 115 min, 80%
            The obtained protein-containing solution was incubated
            at 37°C for 45  min after added with an appropriate   mobile phase B; 115 – 120 min, and 5% mobile phase B.
            amount of 10 mM dithiothreitol. Then, it was treated   The nanoliter liquid phase separation was directly
            with 25 mM iodoacetamide and left in a dark room   connected  to the mass  spectrometer  (BGI, Beijing,
                                                                     30
            for 30  min at room temperature. After trypsinization,   China).  For DDA analysis, LC-separated peptides were
            the solution was incubated for 14 – 16 h at 37°C. The   ionized by nanoESI. They were injected into a tandem mass
            digested peptides for spectral library generation were   spectrometer Q-Exactive HF X (Thermo Fisher Scientific,
            divided into ten fractions with a C18 StageTip. The   San Jose, CA, USA) with DDA detection mode. The main
            Shimadzu  LC-20AB  HPLC  system  coupled  with a   settings were as follows: ion source voltage =  1.9 kV; MS scan
            Gemini high pH C18 column (5 m, 4.6 × 250 mm) was   range = 350–1,500 m/z; MS resolution  = 120,000; maximal
            used. All peptides were frozen, dried, and desalted before   injection time (MIT) = 50 ms; MS/MS collision type = HCD;
            liquid chromatography-tandem mass spectrometry     collision energy (nominal collison energy)  = 28; MS/MS
            (LC-MS/MS) analysis (BGI, Shenzhen, China). 30     resolution = 30,000; MIT = 100 ms; and dynamic exclusion
                                                               duration = 30 s. The start m/z for MS/MS was fixed at 100.
            2.5. Data-dependent acquisition (DDA) and data-    A precursor for MS/MS had the following setting: charge
            independent acquisition (DIA) analysis by nano-    range = 2+ to 6+; top 20 precursors with intensity over 2E4,
            LC-MS/MS                                           and automatic gain control (AGC)  =  MS 3E6, MS/MS 1E5.
            The dried peptide samples were reconstituted with mobile   For DIA analysis, LC-separated peptides were ionized
            phase A (2% acetonitrile [ACN], 0.1% formic acid [FA]),   by nanoESI and injected into tandem mass spectrometer
            centrifuged at 20,000 ×g for 10 min, and the supernatant   Q-Exactive HF X (Thermo Fisher Scientific, San Jose,
            was taken for injection. Separation was carried out by a   CA, USA) with DIA detection mode. The main settings
            Thermo  UltiMate  3000  UHPLC  liquid  chromatography.   were as follows: ion source voltage = 1.9 – 2  kV; MS
            The sample was enriched in the trap column and desalted   scan range  =  400 – 1250 m/z; MS resolution = 120,000;
            and then entered a tandem self-packed C18 column   MIT  =  50 ms; and 400 – 1250 m/z was equally divided into
            (150  µm internal diameter, 1.8  µm column size, 35  cm   a 45 continuous windows of MS/MS scan. MS/MS collision
            column length) and was separated at a flow rate of 500   type  was  collision  dissociation  (HCD),  while  MIT  was
            nL/min by the following effective gradient: 0 – 5 min, 5%   on auto mode. Fragment ions were scanned in Orbitrap,
            mobile phase B (98% ACN, 0.1% FA); 5 – 90 min, mobile   with MS/MS resolution = 30,000, collision energy in the
            phase B linearly increased from 5% to 25%; 90 – 105 min,   distributed mode (22.5, 25, 27.5), and AGC = 1E6.


            Volume 2 Issue 3 (2024)                         4                               doi: 10.36922/jcbp.2381
   47   48   49   50   51   52   53   54   55   56   57